BORTEZOMIB Accord liquid sol inj 3.5 mg/1.4ml
7680682760022
CH-68276
L01XG01
07.16.1.
Reimbursement limitations:
BORTEZACliq
Substitution préparation originale/générique
Aucune nouvelle garantie de prise en charge n'est nécessaire pour le traitement …
1 / 3
google
Details
- Product number
- 6827602
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- bortezomibum 3.5 mg, mannitolum, aqua ad iniectabile, ad solutionem pro 1.4 ml.
Articles (1)
Bortezomib Accord liquid 3.5 mg/1.4 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
3.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 421.85
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2022
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 68276
- Drug name
- Bortezomib Accord liquid, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- L01XG01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 21/10/2021
- Authorization expiration date
- 20/10/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BORTEZOMIB Accord liquid sol inj 3.5 mg/1.4ml
- Description (DE)
- BORTEZOMIB Accord liquid Inj Lös 3.5 mg/1.4ml
- Market launch
- 21/10/2021
- Narcotic (BTM)
- No